New-Clinical-trial-for-curin-B-cell-Cancer
New Clinical trial for curin B-cell Cancer
Senesco Technologies reported the treatment of the first patient at the Company’s newly opened clinical-trial site at Seattle Cancer Care Alliance (SCCA). This patient is part of Senesco’s Phase 1b/2a clinical study of its therapeutic drug candidate, SNS01-T, target...
Tags: B-cell, research, cancer...
October 26, 2013
Novartis-omalizumab-effective-for-severe-urticaria
Novartis' omalizumab effective for severe urticaria
The results of another late stage study of omalizumab (already on the market for asthma as Xolair) support earlier evidence that the drug is safe and effective as a treatment of chronic spontaneous urticaria, a severe form of hives. ...
Tags: omalizumab, Xolair, urticaria, hives, clinical trial, novartis...
October 15, 2013
Dose-dense-temozolomide-shows-no-benefit-for-glioblastoma-patients
Dose-dense temozolomide shows no benefit for glioblastoma patients
The results of a randomized trial showed that radiation therapy and dose-dense temozolomide (Temodar) did not have improved efficacy compared to conventional treatment with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma multiforme....
Tags: temozolomide, Temodar, dose-dense, glioblastoma multiforme, clinical trial...
October 15, 2013
Pfizers-RA-drug-Xeljanz-effective-as-a-treatment-for-psoriasis
Pfizer’s RA drug Xeljanz effective as a treatment for psoriasis
The results of the first two of five Phase 3 trials of Pfizer’s rheumatoid arthritis drug Xeljanz (tofacitinib) , a Janus kinase (JAK) inhibitor, indicate that it might be an effective treatment for adults with moderate-to-severe chronic plaque psoriasis....
Tags: Xeljanz, tofacitinib, plaque psoriasis, clinical trial...
October 14, 2013
Idelalisib-successful-as-a-treatment-for-chronic-lymphocytic-leukemia
Idelalisib successful as a treatment for chronic lymphocytic leukemia
In accordance with a recommendation of a panel of independent monitors, Gilead Sciences has stopped a late-stage clinical trial of Idelalisib, used as a treatment in chronic lymphocytic leukemia patients, due to a clear beneficial effect of the drug in the treated patie...
Tags: Idelalisib, chronic lymphocytic leukemia, Gilead, clinical trial, treatment, PI3K inhibitor...
October 11, 2013
New-Alzheimer-drug-enters-Phase-3-program
New Alzheimer drug enters Phase 3 program
Lundbeck/ Otsuka Pharmaceutical’s investigational compound, Lu AE58054, is entering the first out of four Phase 3 clinical trials for the treatment of Alzheimer's disease. Lu AE58054 has a different proposed mechanism of action than currently available Alzheimer's med...
Tags: Lundbeck, Otsuka, Alzheimer disease, investigational drug, new drug, treatment, clinical trial...
October 11, 2013
Clostridium-C-perfringens-type-bacteria-cures-MS
Clostridium C. perfringens type bacteria cures MS?
Scientists of Weill Cornell Medical College and Rockefeller University used a soil-based bacteria to cure Sclerosis Multiplex. Clostridium C. perfringens type B prooved to be effective in curing a 21-years-old MS patient....
Tags: Multiplex sclerosis, Clostridium C., soil bacteria ...
October 22, 2013
Methotrexate-effective-in-treating-neuromyelitis-optica
Methotrexate effective in treating neuromyelitis optica?
The results of a small study show that oral methotrexate therapy has potential for treating neuromyelitis optica, an autoimmune demyelinating disease affecting retinal nerves and the spinal cord....
Tags: Methotrexate, neuromyelitis optica, treatment...
October 15, 2013
Leukemia-drug-Arzerra-as-a-treatment-for-multiple-sclerosis
Leukemia drug Arzerra as a treatment for multiple sclerosis
GSK and Genmab drug Arzerra (ofatumumab) has shown potential for reducing the number of new brain lesions in relapsing-remitting MS patients, in a Phase 2 study....
Tags: arzerra, GSK, leukemia drug, multiple sclerosis, clinical trial...
October 14, 2013
Removing-Lymph-Node-Helps-to-Cure-Breast-Cancer
Removing Lymph Node Helps to Cure Breast Cancer?
Less removal of lymph nodes is needed according to the new results of scientists. Formerly, when treating breast cancer, all the lymph nodes were removed in order to prevent the injured cells spread in the body. They found out that in some cases there is no need for tha...
Tags: cell, cancer, breast cancer...
October 11, 2013
Qsymia-weight-loss-drug-delays-diabetes-progression
Qsymia weight loss drug delays diabetes progression
A late-stage clinical trial of Vivus’ weight loss drug showed that patients with prediabetes or metabolic syndrome, who were treated with Qsymia, were significantly less likely to develop type 2 diabetes compared to patients who took a placebo....
Tags: Qsymia, weight loss, drug, Vivus, type 2 diabetes...
October 11, 2013
Medivirs-bone-drug-successful-in-Phase-1-clinical-trial
Medivir’s bone drug successful in Phase 1 clinical trial
The investigational cathepsin K inhibitor MIV-711, used as the treatment of osteoarthritis and other bone related disorders, has shown to be safe and tolerable at doses where it potently decreased cartilage degradation and bone resorption....
Tags: Medivir, cathepsin K inhibitor, MIV-711, osteoarthritis, bone, drug, invstigational, clinical trial...
October 10, 2013
MOST VIEWED

HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013